Neomend, Inc.: Series D $30M

Posted in I - Series D, Q - 1Q10, R - WEST, X - Wound Healing, XX - CA

Neomend (Irvine, CA) a commercial-stage developer of sealant and adhesion-prevemtion products focused on the application to visceral pleura for open thoracotomy, closed a $30M Series D financing. Participants include Clarus Ventures, Sanderling Ventures, Novo Ventures, Vivo Ventures and Prospect Venture Partners.

Spiracur, Inc.: Series B $20.3M

Posted in I - Series B, Q - 2Q09, R - WEST, X - Device (Wound Healing), X - Wound Healing, XX - CA

Spiracur (Redwood City, CA) and early-stage medical device company focused on wound healing, closed a $20.3M Series B financing. Participants include Kleiner Perkins Caufield & Byers, New Leaf Venture Partners and De Novo Ventures.

LifeBond, Ltd.: Series B $8M

Posted in I - Series B, Q - 2Q09, R - INTERNATIONAL, X - Biomaterial, X - Hemostasis, X - Wound Healing

LifeBond (Israel) a commercial-stage developer of wound-closure and hemostasis biomaterials, closed a $8M Series B financing. Participants include Pitango Venture Capital, GlenRock Israel and The Zitelman Group.

Adhezion Biomedical, LLC: Series A $2.1M

Posted in I - Series A, Q - 4Q08, R - NORTH EAST, X - Wound Healing

Adhezion Biomedical (Myomissing, PA) an early-stage device company focused on the development differentiated cyanoacrylate-based surgical, wound management and infection prevention technologies closed a $2.1M Series A financing, bringing the round total to $5.3M. Participants include Liberty Venture Partners.

Cohera Medical, Inc.: Series B $16.1M

Posted in I - Series B, Q - 4Q08, R - NORTH EAST, X - Wound Healing

Cohera Medical (Pittsburgh, PA) developer of wound management products and surgical tissue adhesives, closed a $16.1M Series B financing. Participants include Bradford Capital Partners and Kern Whelan Capital.

Celleration Inc.: Series D $30M

Posted in I - Series D, Q - 3Q08, R - MID WEST, X - Wound Healing

Celleration (Eden Prairie, MN) development-stage medical device company focused on wound healing, closed a $30M Series D financing. Participants include Venture Investors, Heron Capital and Clarian Health Ventures.

Celleration, Inc.: Series D $30M

Posted in I - Series D, Q - 3Q08, R - MID WEST, X - Device (Imaging), X - Imaging, X - Wound Healing

Celleration (Eden Prairie, MN) commercial-stage medical device company focused on non-contact ultrasound device for wound care, closed a $25M Series D financing. Participants include Venture Investors, Upper Lake Growth Capital, Baird Venture Partners, Aavin Equity Advisors, Triathlon Medical Ventures and New Science Ventures.

Celleration, Inc.: Series D $25M

Posted in I - Series D, Q - 2Q08, R - MID WEST, X - Wound Healing

Celleration (Eden Prairie, MN) developer of non-contact ultrasound devices for wound-care, closed a $25M Series D financing. Participants include Venture Investors, Upper Lake Growth Capital, Baird Venture Partners, Aavin Equity Advisors, Triathlon Medical Ventures and New Science Ventures.

Histogen, Inc.: Series A $5.4M

Posted in I - Series A, Q - 2Q08, R - WEST, X - Wound Healing

Histogen (San Diego, CA) regenerative medicine company developing solutions based on the fibroblasts, closed a $5.4M Series A financing. Participants include Secure Medical, CellCeuticals Skin Care, and Leonard H. Lavin.

ArGentis Pharmaceuticals, LLC: $2M Series A

Posted in I - Series A, Q - 2Q08, R - SOUTH EAST, X - Autoimmune, X - Opthalmology, X - Wound Healing

ArGentis Pharmaceuticals (Memphis, TN) development-stage biopharmaceutical company focused the development of autoimmunity and ophthalmology therapeutics, closed a $2.0M Series financing. Participants include Innova Memphis.

« Previous Entries

to top of page...